Orforglipron also reduced blood sugar levels in participants with type 2 diabetes
A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood sugar levels, making it a contender to join the new wave of drugs that combat obesity and diabetes.
People who took a 36mg pill of orforglipron lost an average of 7.3kg (16lbs) over nine months, according to results from a phase 3 clinical trial reported by the drug’s manufacturer, Eli Lilly, on Thursday.
About Author
More Stories
Iran blasts Trump for ‘racist mentality’ and hostility to Muslims over travel ban
‘The US was our El Dorado’: Africans on Trump’s travel bans and taxes
Conference to recognise Palestinian state to weaken scope of its ambition, diplomats say